Atlas Trials

Low Grade Serous Ovarian Cancer

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Low Grade Serous Ovarian Cancer

RecordFirmDate
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers (NCT03564340)Regeneron Pharmaceuticals2018-05-21
A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer (NCT01849874)Pfizer2013-06-27

Track Low Grade Serous Ovarian Cancer automatically

Every clearance here is in the API, with alerts when new ones post.